Go Pro

Clover Health Investments (CLOV) Competitors

Clover Health Investments logo
$4.30 +0.08 (+1.77%)
As of 09:46 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CLOV vs. OSCR, HQY, ALHC, UNH, and ELV

Should you buy Clover Health Investments stock or one of its competitors? Clover Health Investments's main competitors and comparable companies include Oscar Health (OSCR), HealthEquity (HQY), Alignment Healthcare (ALHC), UnitedHealth Group (UNH), and Elevance Health (ELV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Clover Health Investments compare to Oscar Health?

Clover Health Investments (NASDAQ:CLOV) and Oscar Health (NYSE:OSCR) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by company insiders. Comparatively, 22.6% of Oscar Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Oscar Health had 6 more articles in the media than Clover Health Investments. MarketBeat recorded 8 mentions for Oscar Health and 2 mentions for Clover Health Investments. Oscar Health's average media sentiment score of 0.58 beat Clover Health Investments' score of 0.42 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Oscar Health
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Clover Health Investments has higher earnings, but lower revenue than Oscar Health. Clover Health Investments is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.19-$85.55M-$0.05N/A
Oscar Health$11.70B0.80-$443.15M$1.4021.79

Clover Health Investments presently has a consensus price target of $4.75, indicating a potential upside of 10.34%. Oscar Health has a consensus price target of $33.90, indicating a potential upside of 11.11%. Given Oscar Health's stronger consensus rating and higher probable upside, analysts clearly believe Oscar Health is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Oscar Health
1 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.31

Clover Health Investments has a beta of 2.45, suggesting that its share price is 145% more volatile than the broader market. Comparatively, Oscar Health has a beta of 2.47, suggesting that its share price is 147% more volatile than the broader market.

Oscar Health has a net margin of 3.60% compared to Clover Health Investments' net margin of -0.74%. Oscar Health's return on equity of 38.45% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-0.74% -4.20% -2.28%
Oscar Health 3.60%38.45%6.76%

Summary

Oscar Health beats Clover Health Investments on 14 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to HealthEquity?

Clover Health Investments (NASDAQ:CLOV) and HealthEquity (NASDAQ:HQY) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

HealthEquity has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.19-$85.55M-$0.05N/A
HealthEquity$1.31B5.70$215.20M$2.7732.66

HealthEquity has a net margin of 17.36% compared to Clover Health Investments' net margin of -0.74%. HealthEquity's return on equity of 15.33% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-0.74% -4.20% -2.28%
HealthEquity 17.36%15.33%9.51%

Clover Health Investments has a beta of 2.45, meaning that its share price is 145% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.24, meaning that its share price is 76% less volatile than the broader market.

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by insiders. Comparatively, 1.6% of HealthEquity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, HealthEquity had 2 more articles in the media than Clover Health Investments. MarketBeat recorded 4 mentions for HealthEquity and 2 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.42 beat HealthEquity's score of 0.13 indicating that Clover Health Investments is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
HealthEquity
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Clover Health Investments currently has a consensus price target of $4.75, suggesting a potential upside of 10.34%. HealthEquity has a consensus price target of $112.20, suggesting a potential upside of 24.02%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
HealthEquity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.92

Summary

HealthEquity beats Clover Health Investments on 13 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Alignment Healthcare?

Clover Health Investments (NASDAQ:CLOV) and Alignment Healthcare (NASDAQ:ALHC) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Alignment Healthcare has a net margin of 0.89% compared to Clover Health Investments' net margin of -0.74%. Alignment Healthcare's return on equity of 20.02% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-0.74% -4.20% -2.28%
Alignment Healthcare 0.89%20.02%3.46%

Clover Health Investments has a beta of 2.45, indicating that its share price is 145% more volatile than the broader market. Comparatively, Alignment Healthcare has a beta of 1.14, indicating that its share price is 14% more volatile than the broader market.

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by company insiders. Comparatively, 5.2% of Alignment Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Clover Health Investments presently has a consensus price target of $4.75, suggesting a potential upside of 10.34%. Alignment Healthcare has a consensus price target of $23.60, suggesting a potential upside of 202.60%. Given Alignment Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Alignment Healthcare is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Alignment Healthcare
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64

Alignment Healthcare has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.19-$85.55M-$0.05N/A
Alignment Healthcare$3.95B0.41-$720K$0.1941.05

In the previous week, Alignment Healthcare had 8 more articles in the media than Clover Health Investments. MarketBeat recorded 10 mentions for Alignment Healthcare and 2 mentions for Clover Health Investments. Alignment Healthcare's average media sentiment score of 0.54 beat Clover Health Investments' score of 0.42 indicating that Alignment Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alignment Healthcare
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Alignment Healthcare beats Clover Health Investments on 13 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to UnitedHealth Group?

Clover Health Investments (NASDAQ:CLOV) and UnitedHealth Group (NYSE:UNH) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

Clover Health Investments currently has a consensus price target of $4.75, suggesting a potential upside of 10.34%. UnitedHealth Group has a consensus price target of $465.75, suggesting a potential upside of 27.37%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, analysts plainly believe UnitedHealth Group is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
UnitedHealth Group
0 Sell rating(s)
8 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.71

In the previous week, UnitedHealth Group had 11 more articles in the media than Clover Health Investments. MarketBeat recorded 13 mentions for UnitedHealth Group and 2 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.42 beat UnitedHealth Group's score of 0.33 indicating that Clover Health Investments is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
UnitedHealth Group
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Clover Health Investments has a beta of 2.45, suggesting that its share price is 145% more volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

UnitedHealth Group has a net margin of 3.14% compared to Clover Health Investments' net margin of -0.74%. UnitedHealth Group's return on equity of 16.53% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-0.74% -4.20% -2.28%
UnitedHealth Group 3.14%16.53%5.43%

UnitedHealth Group has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.19-$85.55M-$0.05N/A
UnitedHealth Group$447.57B0.73$12.06B$15.5423.53

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by company insiders. Comparatively, 0.2% of UnitedHealth Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

UnitedHealth Group beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Elevance Health?

Elevance Health (NYSE:ELV) and Clover Health Investments (NASDAQ:CLOV) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.42$5.66B$22.5017.03
Clover Health Investments$1.92B1.19-$85.55M-$0.05N/A

Elevance Health presently has a consensus price target of $440.90, indicating a potential upside of 15.06%. Clover Health Investments has a consensus price target of $4.75, indicating a potential upside of 10.34%. Given Elevance Health's stronger consensus rating and higher possible upside, research analysts plainly believe Elevance Health is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17

Elevance Health has a net margin of 2.47% compared to Clover Health Investments' net margin of -0.74%. Elevance Health's return on equity of 14.64% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
Clover Health Investments -0.74%-4.20%-2.28%

Elevance Health has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.45, suggesting that its share price is 145% more volatile than the broader market.

In the previous week, Elevance Health had 1 more articles in the media than Clover Health Investments. MarketBeat recorded 3 mentions for Elevance Health and 2 mentions for Clover Health Investments. Elevance Health's average media sentiment score of 1.02 beat Clover Health Investments' score of 0.42 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Elevance Health beats Clover Health Investments on 13 of the 16 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLOV vs. The Competition

MetricClover Health InvestmentsHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.28B$9.59B$7.22B$13.08B
Dividend YieldN/A2.60%2.53%15.88%
P/E Ratio-85.8833.83272.6425.80
Price / Sales1.194.88607.4990.99
Price / CashN/A120.2777.3851.29
Price / Book7.305.1210.886.26
Net Income-$85.55M$315.68M$3.50B$360.95M
7 Day Performance-4.12%-3.34%-2.03%-1.81%
1 Month Performance0.12%-3.28%-6.43%-4.03%
1 Year Performance70.16%7.89%8.95%2.18%

Clover Health Investments Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLOV
Clover Health Investments
2.8108 of 5 stars
$4.31
+1.8%
$4.75
+10.3%
+61.5%$2.28B$1.92BN/A724
OSCR
Oscar Health
4.6124 of 5 stars
$28.89
-5.4%
$33.90
+17.3%
+57.9%$9.47B$11.70B20.632,305
HQY
HealthEquity
4.2339 of 5 stars
$88.60
-2.0%
$112.20
+26.6%
-1.5%$7.59B$1.31B31.992,814
ALHC
Alignment Healthcare
4.3175 of 5 stars
$7.67
-2.4%
$23.60
+207.7%
-54.0%$1.66B$3.95B40.371,849
UNH
UnitedHealth Group
4.9792 of 5 stars
$374.98
+1.0%
$456.56
+21.8%
+5.0%$333.27B$450.13B24.13390,000

Related Companies and Tools


This page (NASDAQ:CLOV) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners